Literature DB >> 4376505

Cell relationships in transformation of human leukocytes by Epstein-Barr virus.

J H Pope, W Scott, D J Moss.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4376505     DOI: 10.1002/ijc.2910140115

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  7 in total

1.  Inhibition of the in vitro outgrowth of Epstein-Barr virus-transformed lymphocytes by thymus-dependent lymphocytes from infectious mononucleosis patients.

Authors:  A B Rickinson; D Crawford; M A Epstein
Journal:  Clin Exp Immunol       Date:  1977-04       Impact factor: 4.330

2.  Inhibition of EB virus transformation of non-adherent human lymphocytes by co-cultivation with adult fibroblasts.

Authors:  D J Moss; J H Pope; W Scott
Journal:  Med Microbiol Immunol       Date:  1976-12-01       Impact factor: 3.402

3.  [Isoenzyme pattern of acid phosphatase in epstein-barr-virus-DNA positive permanent growing lymphoid cell lines (author's transl)].

Authors:  H W Heyden; R Weber; H Stuckstedte; J G Saal; K O Fresen
Journal:  Blut       Date:  1977-11-22

4.  Clonal transformation of adult human leukocytes by Epstein-Barr virus.

Authors:  B Sugden; W Mark
Journal:  J Virol       Date:  1977-09       Impact factor: 5.103

5.  Establishment of peripheral lymphoid cell cultures from patients with Hodgkin's disease depending on Epstein-Barr-Virus-reactivity and cellular immunity.

Authors:  V Diehl; B Johansson
Journal:  Blut       Date:  1977-03

6.  Patients with congenital myasthenia associated with end-plate acetylcholinesterase deficiency show normal sequence, mRNA splicing, and assembly of catalytic subunits.

Authors:  S Camp; S Bon; Y Li; D K Getman; A G Engel; J Massoulié; P Taylor
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

7.  Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes.

Authors:  D A Thorley-Lawson; L Chess; J L Strominger
Journal:  J Exp Med       Date:  1977-08-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.